Company's senior V.P. of R&D describes a 'truly rewarding' product development process.
Report analyzes 82,841 hip arthroplasties and 128,880 knee arthroplasties from 2012-2014.
Cleared to market medical devices in 33 European countries.
Proprietary approach layers titanium scaffold surface technology on PEEK implants creating differentiated devices.
AdvaMed leadership discusses states' efforts to alleviate the tax's pressure and details findings from the group's latest report.
The implant is targeted at young and active patients.
When it comes to establishing enterprise-wide quality procedures for orthopedic manufacturers, it takes more than a single approach to create a robust system.
Technology is based on Zeniva PEEK resin from Solvay Specialty Polymers.
CEO outlines plan for a ‘more lean and mean, cost competitive’ company.
Company will initiate a limited launch this year, with a full rollout in 2016.
Sign up now to receive the free weekly newsletter, and more!